1-methyltryptophan has been researched along with Carcinoma, Lewis Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Kuang, C; Li, X; Li, Y; Yan, J; Yang, Q; Yang, S; Yang, Y | 1 |
| Cheng, J; Li, Z; Liu, M; Ma, B; Min, W; Wang, H; Wang, L; Yao, W; Zeng, X; Zhang, R | 1 |
| Calleja, P; Espuelas, S; Irache, JM; MartÃnez-Oharriz, C; Zandueta, C | 1 |
| Le, V; Lin, S; Liu, J; Que, Z; Tian, J; Zhang, A; Zhang, L; Zheng, Y | 1 |
4 other study(ies) available for 1-methyltryptophan and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung Neoplasms; Mice; Molecular Structure; Quinazolines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2013 |
IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion.
Topics: Animals; B7-H1 Antigen; Carcinoma, Lewis Lung; Combined Modality Therapy; Dendritic Cells; Drug Resistance, Neoplasm; Flow Cytometry; Galectins; Gene Expression Regulation, Neoplastic; Hepatitis A Virus Cellular Receptor 2; Indoleamine-Pyrrole 2,3,-Dioxygenase; Ligands; Programmed Cell Death 1 Receptor; Receptors, Immunologic; T-Lymphocytes, Regulatory; Tryptophan | 2020 |
A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Inbred C57BL; Nanoparticles; Paclitaxel; Particle Size; Solubility; Tryptophan; X-Ray Diffraction | 2017 |
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Coculture Techniques; Disease Progression; Drug Screening Assays, Antitumor; Female; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, Inbred C57BL; Neoplasm Transplantation; Paclitaxel; Saponins; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Triterpenes; Tryptophan; Tumor Burden; Tumor Escape | 2014 |